Venus Medtech (Hangzhou) Inc. announced Poll Results of the 2023 Fourth Extraordinary General Meeting approved To elect Mr. Liqiao Ma as an executive director of the Company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.62 HKD | -0.71% | -.--% | -.--% |
01/04 | Venus Medtech Trims Loss in 2023 as Revenue Grows Nearly 21% | MT |
28/03 | Venus Medtech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-.--% | 315M | |
+9.96% | 127B | |
-6.58% | 10.91B | |
+2.70% | 9.24B | |
-19.67% | 7.44B | |
+34.49% | 5.44B | |
+8.18% | 3.44B | |
-9.55% | 2.87B | |
-5.57% | 2.25B | |
-0.60% | 2.23B |
- Stock Market
- Equities
- 2500 Stock
- News Venus Medtech (Hangzhou) Inc.
- Venus Medtech Inc. Approves Mr. Liqiao Ma as an Executive Director